MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.phrs.2021.105445

Медицинская библиотека · Pharmacological research · 2021

Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation.

Galvão Izabela, Melo Eliza M, de Oliveira Vivian L S, Vago Juliana P, Queiroz-Junior Celso, de Gaetano Monica, Brennan Eoin, Gahan Kevin, Guiry Patrick J, Godson Catherine, Teixeira Mauro M

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

The resolution of inflammation is a dynamic process, characterized by the biosynthesis of pro-resolving mediators, including the lipid Lipoxin A4 (LXA4). LXA4 acts on the N-formyl peptide receptor 2 (FPR2/ALX) to mediate anti-inflammatory and pro-resolving effects. In order to exploit the therapeutic potential of endogenous LXA4 in the context of inflammation we have recently developed synthetic LXA4 mimetics (sLXms) including a dimethyl-imidazole-containing FPR2/ALX agonist designated AT-01-KG. Here, we have investigated the effect of treatment with AT-01-KG in established models of articular inflammation. In a model of gout, mice were injected with MSU crystals and treated with AT-01-KG at the peak of inflammatory response. The treatment decreased the number of neutrophils in the knee exudate, an effect which was accompanied by low levels of myeloperoxidase, CXCL1 and IL-1β in periarticular tissue. AT-01-KG treatment led to reduced tissue damage and hypernociception. The effects of AT-01-KG on neutrophil accumulation were not observed in MSU treated FPR2/3-/-mice. Importantly, AT-01-KG induced resolution of articular inflammation by increasing neutrophil apoptosis and subsequent efficient efferocytosis. In a model of antigen-induced arthritis, AT-01-KG treatment also attenuated inflammatory responses. These data suggest that AT-01-KG may be a potential new therapy for neutrophilic inflammation of the joints.

Для цитирования: Galvão Izabela, Melo Eliza M, de Oliveira Vivian L S, Vago Juliana P, Queiroz-Junior Celso, de Gaetano Monica, Brennan Eoin, Gahan Kevin, Guiry Patrick J, Godson Catherine, Teixeira Mauro M. Therapeutic potential of the FPR2/ALX agonist AT-01-KG in the resolution of articular inflammation.. Pharmacological research. 2021. DOI: 10.1016/j.phrs.2021.105445.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.